Sakura Finetek Launches New Advanced Staining System

The Tissue-Tek Genie Advanced Staining System is the first and only fully automated, true random access stainer for immunohistochemistry (IHC) and in situ hybridisation (ISH); thanks to its innovative technology makes it uncompromisingly fast, providing a predictable case turnaround time. With this groundbreaking system, the company enters a new market. The launch of Genie demonstrates the company’s commitment to supporting the provision of the next-generation immunohistochemistry solution.

By continuous 3rd-party clinical validation performed by NordiQC, Sakura Finetek provides optimal scoring antibodies only, focusing on the optimal result for pathologists and their patients. Tissue-Tek Genie is extending Sakura’s wide range of standardizing pre-analytical instruments. The company has a long history of technological innovations. Sakura Finetek had launched the first fully enclosed tissue processor: Tissue-Tek VIP, the first rapid tissue processor: Tissue-Tek Xpress and the first automated embedding system: Tissue-Tek AutoTEC. The Tissue-Tek Genie fits perfectly in that line and brings enormous opportunities for future innovations.

“I’m thrilled and proud with the launch of this innovative solution,” said Chris Koeman, President of Sakura Finetek Europe. “This underlines our company’s mission: empowering pathology professionals to deliver accurate and fast diagnoses to optimize treatment success for each life we touch.”

“This is a next-generation advanced staining system, a game changer in the complex world of advanced staining,” said Mateo Iglesias, Vice-President of Marketing and Sales. “Genie drives quality and standardization of every single slide, allowing our customers to make a confident diagnostic decision with a system that will guarantee consistent and optimal results.”

Related Links:
Sakura Finetek Europe